MedPath

Procaterol

Generic Name
Procaterol
Drug Type
Small Molecule
Chemical Formula
C16H22N2O3
CAS Number
72332-33-3
Unique Ingredient Identifier
X7I3EMM5K0
Background

A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.

Indication

For the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Associated Conditions
Bronchial Asthma, Bronchospasm, Chronic Bronchitis, Emphysema

Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease

Phase 4
Completed
Conditions
COPD
Interventions
First Posted Date
2024-04-04
Last Posted Date
2025-01-20
Lead Sponsor
Thammasat University
Target Recruit Count
20
Registration Number
NCT06346691
Locations
🇹🇭

Narongkorn Saiphoklang, Klongluang, Pathumthani, Thailand

Effect of Oral Procaterol on Postinfectious Persistent Cough

Not Applicable
Conditions
Cough
Interventions
Drug: Placebo
First Posted Date
2015-01-29
Last Posted Date
2017-03-23
Lead Sponsor
Mahidol University
Target Recruit Count
74
Registration Number
NCT02349919
Locations
🇹🇭

Ramathibodi Hospital, Bangkok, Thailand

Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.

Phase 1
Completed
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Interventions
First Posted Date
2014-06-17
Last Posted Date
2015-06-03
Lead Sponsor
Intech Biopharm Ltd.
Target Recruit Count
24
Registration Number
NCT02165046
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA)

Phase 4
Conditions
Cough Variant Asthma
Interventions
First Posted Date
2010-07-27
Last Posted Date
2010-07-27
Lead Sponsor
Shanghai Jiao Tong University School of Medicine
Target Recruit Count
160
Registration Number
NCT01170429
Locations
🇨🇳

Xin Zhou, Shanghai, Shanghai, China

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients

Phase 3
Completed
Conditions
Asthma
Interventions
First Posted Date
2010-03-29
Last Posted Date
2013-01-16
Lead Sponsor
Taiwan Otsuka Pharm. Co., Ltd
Target Recruit Count
32
Registration Number
NCT01095016
Locations
🇨🇳

Chang Cung Memorial Hospital, Taipei, Taiwan

Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room

Phase 4
Completed
Conditions
Asthma
Interventions
First Posted Date
2010-03-24
Last Posted Date
2010-03-24
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
96
Registration Number
NCT01091337
Locations
🇵🇭

Philippine General Hospital, Manila, Philippines

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients

Phase 3
Completed
Conditions
Asthma
Interventions
First Posted Date
2010-02-26
Last Posted Date
2010-08-12
Lead Sponsor
Taiwan Otsuka Pharm. Co., Ltd
Target Recruit Count
17
Registration Number
NCT01076322
Locations
🇨🇳

Taiwan University Hospital, Taipei, Taiwan

Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

Phase 4
Terminated
Conditions
Pulmonary Disease, Chronic Obstructive
First Posted Date
2006-11-01
Last Posted Date
2009-12-17
Lead Sponsor
Otsuka Pharmaceutical, Inc., Philippines
Target Recruit Count
50
Registration Number
NCT00394485
Locations
🇵🇭

Philippine General Hospital, Manila, National Capital Region, Philippines

© Copyright 2025. All Rights Reserved by MedPath